Synopsis
Synopsis
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
VMF
0
Europe
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
Annual Reports
NA
1. 2 Phenethylhydrazine
2. 2-phenethylhydrazine
3. Beta Phenylethylhydrazine
4. Beta-phenylethylhydrazine
5. Fenelzin
6. Nardelzine
7. Nardil
8. Phenelzine
9. Phenethylhydrazine
10. Sulfate, Phenelzine
1. 156-51-4
2. Phenelzine Sulfate Salt
3. Estinerval
4. Nardelzine
5. Phenelzine Sulphate
6. Phenelzine (sulfate)
7. Phenethylhydrazine Sulfate
8. Phenethylhydrazin
9. Mao-rem
10. Phenelzine Bisulfate
11. Phenylethylhydrazine Sulfate
12. Phenelzine Acid Sulfate
13. Phenelzine Hydrogen Sulfate
14. Hydrazine, (2-phenylethyl)-, Sulfate (1:1)
15. Phenalzine Dihydrogen Sulfate
16. Phenelzine Dihydrogen Sulfate
17. Wl 7
18. Phenethylhydrazine Sulfate (1:1)
19. N-1544a
20. 2-phenylethylhydrazine Dihydrogen Sulfate
21. (2-phenylethyl)hydrazine Sulfate
22. 2-phenylethylhydrazine;sulfuric Acid
23. S 1544
24. Phenelzine Sulfate [usp]
25. Hydrazine, (2-phenylethyl)-, Sulfate
26. Nsc-170957
27. 156-51-4 (sulfate)
28. Chebi:8061
29. Alacine
30. Alazin
31. 2681d7p965
32. Dsstox_cid_1144
33. Phenelzine Sulfate (usp)
34. Dsstox_rid_75973
35. Dsstox_gsid_21144
36. Phenelzine Hydrogen Sulphate
37. Phenelzine Bisulphate
38. Phenethylhydrazine Sulphate
39. Phenylethylhydrazine Sulphate
40. Smr000058500
41. Ccris 498
42. 2-phenylethylhydrazine Sulphate
43. Beta-phenylethylhydrazine Sulfate
44. Sr-01000076074
45. Einecs 205-856-0
46. Ep-411
47. Nsc 170957
48. Phenylethylhydrazine Dihydrogen Sulphate
49. 2-phenylethylhydrazine Hydrogen Sulphate
50. Felazine
51. Phelazin
52. Phenelzin
53. Phenline
54. 2-phenylethylhydrazine Dihydrogen Sulphate
55. Beta-phenylethylhydrazine Hydrogen Sulphate
56. Beta-phenylethylhydrazine Dihydrogen Sulfate
57. Phenelzinesulfate
58. 1-hydrazino-2-phenylethane Hydrogen Sulphate
59. P 1531
60. Unii-2681d7p965
61. Prestwick_595
62. Mfcd00050687
63. Nardil (tn)
64. Phenylaethyl-hydrazin
65. W 1544a
66. Hydrazine, Phenethyl-, Sulfate (1:1)
67. Phenelzine-[d4] Sulfate
68. Phenethyl Hydrazine Sulfate
69. Schembl40652
70. 2-phenethyl-hydrazine Sulfate
71. 2-phenylethylhydrazine Sulfate
72. Mls000069778
73. Mls000758253
74. Mls001423996
75. Spectrum1500476
76. Chembl1200895
77. Dtxsid3021144
78. 2-phenethylhydrazine Sulfate Salt
79. Hms500d04
80. Hy-b1018a
81. Phenelzine Sulfate [iarc]
82. Hms1568b21
83. Hms1920j08
84. Hms2051i11
85. Hms2091n20
86. Hms2095b21
87. Hms2233n22
88. Hms3263c03
89. Hms3393i11
90. Hms3712b21
91. Pharmakon1600-01500476
92. Phenelzine Sulfate [vandf]
93. .beta.-phenylethylhydrazine Sulfate
94. Phenelzine Sulfate [mart.]
95. Phenelzine Sulfate [usp-rs]
96. Phenelzine Sulfate [who-dd]
97. Tox21_110236
98. Tox21_200134
99. Tox21_500971
100. Ccg-40227
101. Nsc170957
102. Nsc757268
103. Phenelzine Acid Sulfate [mi]
104. (2-phenylethyl)hydrazine Sulfuric Acid
105. Akos015914085
106. Tox21_110236_1
107. Cs-4533
108. Lp00971
109. Nc00037
110. Nsc-757268
111. Phenelzine Sulfate [orange Book]
112. Ncgc00015830-08
113. Ncgc00094271-01
114. Ncgc00094271-02
115. Ncgc00094271-03
116. Ncgc00094271-04
117. Ncgc00094271-05
118. Ncgc00257688-01
119. Ncgc00261656-01
120. Phenelzine Sulfate [usp Monograph]
121. Phenethylhydrazine Sulphate (1:1)
122. Eu-0100971
123. Ft-0673678
124. .beta.-phenylethylhydrazine Dihydrogen Sulfate
125. C07431
126. D00505
127. P 6777
128. J-009308
129. Sr-01000076074-1
130. Sr-01000076074-6
131. Sr-01000076074-8
132. Hydrazine, (2-phenylethyl)-, Sulphate (1:1)
133. Q27107688
134. Phenelzine Sulfate, United States Pharmacopeia (usp) Reference Standard
135. Wln: Zm2r & Wsqqalacinealazineep-411estinervalfenelsinfenetsinfenelzinafenizinkalganmao-remmonofenmonophenmonoten
Molecular Weight | 234.28 g/mol |
---|---|
Molecular Formula | C8H14N2O4S |
Hydrogen Bond Donor Count | 4 |
Hydrogen Bond Acceptor Count | 6 |
Rotatable Bond Count | 3 |
Exact Mass | 234.06742811 g/mol |
Monoisotopic Mass | 234.06742811 g/mol |
Topological Polar Surface Area | 121 Ų |
Heavy Atom Count | 15 |
Formal Charge | 0 |
Complexity | 159 |
Isotope Atom Count | 0 |
Defined Atom Stereocenter Count | 0 |
Undefined Atom Stereocenter Count | 0 |
Defined Bond Stereocenter Count | 0 |
Undefined Bond Stereocenter Count | 0 |
Covalently Bonded Unit Count | 2 |
1 of 2 | |
---|---|
Drug Name | Phenelzine sulfate |
Drug Label | Phenelzine Sulfate Tablets, USP (phenelzine sulfate) is a potent inhibitor of monoamine oxidase(MAO). Phenelzine sulfate is a hydrazine derivative. It has a molecular weight of 234.27 and is chemically described as C8H12N2 H2SO4. Its chemical stru... |
Active Ingredient | Phenelzine sulfate |
Dosage Form | Tablet |
Route | Oral |
Strength | eq 15mg base |
Market Status | Prescription |
Company | Novel Labs |
2 of 2 | |
---|---|
Drug Name | Phenelzine sulfate |
Drug Label | Phenelzine Sulfate Tablets, USP (phenelzine sulfate) is a potent inhibitor of monoamine oxidase(MAO). Phenelzine sulfate is a hydrazine derivative. It has a molecular weight of 234.27 and is chemically described as C8H12N2 H2SO4. Its chemical stru... |
Active Ingredient | Phenelzine sulfate |
Dosage Form | Tablet |
Route | Oral |
Strength | eq 15mg base |
Market Status | Prescription |
Company | Novel Labs |
Antidepressive Agents
Mood-stimulating drugs used primarily in the treatment of affective disorders and related conditions. Several MONOAMINE OXIDASE INHIBITORS are useful as antidepressants apparently as a long-term consequence of their modulation of catecholamine levels. The tricyclic compounds useful as antidepressive agents (ANTIDEPRESSIVE AGENTS, TRICYCLIC) also appear to act through brain catecholamine systems. A third group (ANTIDEPRESSIVE AGENTS, SECOND-GENERATION) is a diverse group of drugs including some that act specifically on serotonergic systems. (See all compounds classified as Antidepressive Agents.)
Monoamine Oxidase Inhibitors
A chemically heterogeneous group of drugs that have in common the ability to block oxidative deamination of naturally occurring monoamines. (From Gilman, et al., Goodman and Gilman's The Pharmacological Basis of Therapeutics, 8th ed, p414) (See all compounds classified as Monoamine Oxidase Inhibitors.)
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4328
Submission : 1981-10-02
Status : Active
Type : II
NDC Package Code : 46016-1562
Start Marketing Date : 2003-09-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : Reviewed
Rev. Date : 2017-07-11
Pay. Date : 2017-01-09
DMF Number : 31303
Submission : 2017-01-12
Status : Active
Type : II
NDC Package Code : 60862-004
Start Marketing Date : 2016-08-30
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (10kg/10kg)
Marketing Category : BULK INGREDIENT
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7790
Submission : 1988-11-28
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18400
Submission : 2005-06-10
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 18400
Submission : 2005-06-10
Status : Inactive
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 4328
Submission : 1981-10-02
Status : Active
Type : II
GDUFA
DMF Review : N/A
Rev. Date :
Pay. Date :
DMF Number : 7790
Submission : 1988-11-28
Status : Active
Type : II
GDUFA
DMF Review : Complete
Rev. Date : 2017-07-11
Pay. Date : 2017-01-09
DMF Number : 31303
Submission : 2017-01-12
Status : Active
Type : II
NDC Package Code : 46016-1562
Start Marketing Date : 2003-09-01
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (50kg/50kg)
Marketing Category : BULK INGREDIENT
NDC Package Code : 60862-004
Start Marketing Date : 2016-08-30
End Marketing Date : 2024-12-31
Dosage Form (Strength) : POWDER (10kg/10kg)
Marketing Category : BULK INGREDIENT
About the Company : Procos S.p.A. is a wholly owned subsidiary of the Japanese company, CBC Co. Ltd Group, specializing in the development, scale-up and production of Active Pharmaceutical Ingredients...
About the Company : As an internationally renowned outsourcing partner, we offer products and tailor-made service packages that are seamlessly embedded in the value chain of our customers. Our pharmac...
Regulatory Info :
Registration Country : Australia
Brand Name : Nardil
Dosage Form : tablet
Dosage Strength : 15 mg
Packaging : 100
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Nardil (Canada)
Dosage Form :
Dosage Strength :
Packaging : 60
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info : RX
Registration Country : USA
Brand Name : PHENELZINE SULFATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 15MG BASE
Packaging :
Approval Date : 2010-12-08
Application Number : 200181
Regulatory Info : RX
Registration Country : USA
Regulatory Info : RX
Registration Country : USA
Brand Name : NARDIL
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 15MG BASE
Packaging :
Approval Date : 1982-01-01
Application Number : 11909
Regulatory Info : RX
Registration Country : USA
Regulatory Info : Prescription
Registration Country : Canada
PHENELZINE (PHENELZINE SULFATE)
Brand Name : NARDIL
Dosage Form : TABLET
Dosage Strength : 15MG
Packaging : 100
Approval Date :
Application Number : 476552
Regulatory Info : Prescription
Registration Country : Canada
RLD : No
TE Code : AB
Brand Name : PHENELZINE SULFATE
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 15MG BASE
Approval Date : 2010-12-08
Application Number : 200181
RX/OTC/DISCN : RX
RLD : No
TE Code : AB
RLD : Yes
TE Code : AB
Brand Name : NARDIL
Dosage Form : TABLET;ORAL
Dosage Strength : EQ 15MG BASE
Approval Date : 1982-01-01
Application Number : 11909
RX/OTC/DISCN : RX
RLD : Yes
TE Code : AB
Regulatory Info : Prescription
Registration Country : Canada
PHENELZINE (PHENELZINE SULFATE)
Brand Name : NARDIL
Dosage Form : TABLET
Dosage Strength : 15MG
Packaging : 100
Approval Date :
Application Number : 476552
Regulatory Info : Prescription
Registration Country : Canada
Regulatory Info :
Registration Country : Australia
Brand Name : Nardil
Dosage Form : tablet
Dosage Strength : 15 mg
Packaging : 100
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Regulatory Info :
Registration Country : Australia
Brand Name : Nardil (Canada)
Dosage Form :
Dosage Strength :
Packaging : 60
Approval Date :
Application Number :
Regulatory Info :
Registration Country : Australia
Related Excipient Companies
Excipients by Applications
Global Sales Information
Market Place
REF. STANDARDS & IMPURITIES
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?